Search
for
Sort by
Research 391–420 of 1000+
- Hair regrowth with novel hemp extract: A case series
- The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms
- Hair Growth-Promoting Effects of a Multi-Targeted Cosmetic Formulation Containing PYGL, DP2, and 15-PGDH Inhibitors Developed Using AI-Based DeepZema® in Androgenetic Alopecia: A 24-Week Randomized Controlled Trial
- Exploring the role of CYP19A1 single nucleotide polymorphisms in the pathogenesis of female pattern hair loss
- Female pattern hair loss: therapeutic update
- Anti-Hair Loss Effect of Adenosine Is Exerted by cAMP Mediated Wnt/β-Catenin Pathway Stimulation via Modulation of Gsk3β Activity in Cultured Human Dermal Papilla Cells
- <i>Saccharomyces cerevisiae</i> BLYAS, a New Bioluminescent Bioreporter for Detection of Androgenic Compounds
- Androgenetic Alopecia: a Review and Emerging Treatments
- Mixed-Culture Fermentation of Coffee Pulp Induces Metabolomic Changes and Enhances Multi-Target Bioactivity Relevant to Androgenetic Alopecia
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- Placental mRNA Expression of Neurokinin B Is Increased in PCOS Pregnancies with Female Offspring
- Targeting integrin pathways: mechanisms and advances in therapy
- PPAR‐γ signalling as a key mediator of human hair follicle physiology and pathology
- Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
- Hematological and hepatic effects of vascular epidermal growth factor (VEGF) used to stimulate hair growth in an animal model
- Androgenetic Alopecia: An Update of Treatment Options
- Female pattern alopecia: current perspectives
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- A Canadian Consensus on Androgenetic Alopecia: Approach and Management
- Epidemiological landscape of androgenetic alopecia in the US: An All of Us cross-sectional study
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations
- Aqueous Dispersion of Unmodified Fullerene C60: Stimulation of Hair Growth and Study of a New Molecular Target for Interaction
- Cancer-Related Alopecia Risk and Treatment
- An Updated Etiology of Hair Loss and the New Cosmeceutical Paradigm in Therapy: Clearing ‘the Big Eight Strikes’
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- 3α-androstanediol, but not testosterone, attenuates age-related decrements in cognitive, anxiety, and depressive behavior of male rats
- Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics